Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Bich Trinh

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|December 5, 2017
The role of Nuclear Factor-kappa B signaling in human cervical cancerSam Tilborghs, Jerome Corthouts, Yannick Verhoeven, et al.
Fertility and Sterility|August 21, 2007
Use of the levonorgestrel-releasing intrauterine system in breast cancer patientsXuan Bich Trinh, Wiebren A A Tjalma, Amin P Makar, et al.
Obstetrics and Gynecology International|September 24, 2011
Are costs of robot-assisted surgery warranted for gynecological procedures?Peter van Dam, Jan Hauspy, Luc Verkinderen, et al.
Cell Cycle (Georgetown, Tex.)|February 28, 2013
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasionMamadou Keita, Magdalena Bachvarova, Chantale Morin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 25, 2019
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trialsOmar Najim, Sofie Seghers, Laurine Sergoynne, et al.
International Journal of Molecular Sciences|March 6, 2021
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief UpdateYannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, et al.
Gynecologic Oncology|June 20, 2017
Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft modelsTine Cuppens, Jeroen Depreeuw, Daniela Annibali, et al.
ESMO Open|July 19, 2018
Potential new biomarkers for squamous carcinoma of the uterine cervixPeter A van Dam, Christian Rolfo, Rossana Ruiz, et al.
Plos One|October 15, 2013
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cellsZhi-Qiang Wang, Mamadou Keita, Magdalena Bachvarova, et al.
Cancer Treatment and Research Communications|March 4, 2019
The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)Omar Najim, Manon Huizing, Konstantinos Papadimitriou, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|December 5, 2017
The role of Nuclear Factor-kappa B signaling in human cervical cancerSam Tilborghs, Jerome Corthouts, Yannick Verhoeven, et al.
Fertility and Sterility|August 21, 2007
Use of the levonorgestrel-releasing intrauterine system in breast cancer patientsXuan Bich Trinh, Wiebren A A Tjalma, Amin P Makar, et al.
Obstetrics and Gynecology International|September 24, 2011
Are costs of robot-assisted surgery warranted for gynecological procedures?Peter van Dam, Jan Hauspy, Luc Verkinderen, et al.
Cell Cycle (Georgetown, Tex.)|February 28, 2013
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasionMamadou Keita, Magdalena Bachvarova, Chantale Morin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 25, 2019
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trialsOmar Najim, Sofie Seghers, Laurine Sergoynne, et al.
International Journal of Molecular Sciences|March 6, 2021
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief UpdateYannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, et al.
Gynecologic Oncology|June 20, 2017
Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft modelsTine Cuppens, Jeroen Depreeuw, Daniela Annibali, et al.
ESMO Open|July 19, 2018
Potential new biomarkers for squamous carcinoma of the uterine cervixPeter A van Dam, Christian Rolfo, Rossana Ruiz, et al.
Plos One|October 15, 2013
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cellsZhi-Qiang Wang, Mamadou Keita, Magdalena Bachvarova, et al.
Cancer Treatment and Research Communications|March 4, 2019
The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)Omar Najim, Manon Huizing, Konstantinos Papadimitriou, et al.
Pageof 4